ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,907Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 206

$456K Total Retail Price of All Prescriptions

Rank: 5 out of 206

204 Patients Receiving at Least One Drug in Part D
23%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

31% of this provider’s 204 patients filled at least one prescription for a schedule two drug, compared to an average of 15%.

Schedule Three
Controlled Substances

30% of this provider’s 204 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

0% of this provider’s 2,427 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
OMEPRAZOLE 435 103 1 4
HYDROCODONE-ACETAMINOPHEN 372 73 S3 2 1
LISINOPRIL 293 93 3 2
OXYCODONE HCL 271 104 S2 4 10
LEVOTHYROXINE SODIUM 213 70 5 3
HYDROCHLOROTHIAZIDE 208 106 6 9
PROAIR HFA 178 68 7 37
METFORMIN HCL 174 32 8 6
LOVASTATIN 171 110 9 13
GABAPENTIN 166 38 10 12
FUROSEMIDE 163 59 11 7
SIMVASTATIN 162 51 12 5
TRAZODONE HCL 145 41 13 23
CYCLOBENZAPRINE HCL 143 0 R 14 28
ATENOLOL 131 47 15 17
METHADONE HCL 128 0 S2 16 33
OXYCONTIN 123 0 S2 17 42
ADVAIR DISKUS 121 32 18 32
TRAMADOL HCL 118 12 19 27
POTASSIUM CHLORIDE 116 55 20 16
IBUPROFEN 108 0 21 39
ATORVASTATIN CALCIUM 107 38 22 15
METOPROLOL TARTRATE 104 66 23 14
AMITRIPTYLINE HCL 103 12 R 24 59
MORPHINE SULFATE ER 103 0 S2 24 19
RANITIDINE HCL 99 28 26 26
METOPROLOL SUCCINATE 94 68 27 18
AMLODIPINE BESYLATE 86 75 28 8
CLONIDINE HCL 77 25 29 119
MORPHINE SULFATE 73 0 S2 30 81
OXYBUTYNIN CHLORIDE 72 0 31 85
METHOCARBAMOL 72 0 R 31 69
DOXEPIN HCL 71 17 33 118
VENLAFAXINE HCL ER 69 20 34 90
WARFARIN SODIUM 61 29 35 21
BACLOFEN 61 20 35 93
VERAPAMIL ER 60 0 37 165
PRAZOSIN HCL 57 18 38 173
HYDROXYZINE PAMOATE 56 0 R 39 102
FLUOXETINE HCL 55 15 40 45
DICLOFENAC SODIUM 54 0 41 129
LORATADINE 53 27 42 183
CARBIDOPA-LEVODOPA 53 17 42 105
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 27 44 51
TIZANIDINE HCL 51 27 44 44
COMBIVENT 50 0 46 134
PRENATAL PLUS 50 13 46 191
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.